The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.

As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and PreventionSK bioscience is jointly ...

Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing ...

Researchers across the world are working on a hantavirus vaccine, though they say development is in the early stages and rollout could be years away.

INCHEON, South Korea, June 9, 2026 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that, ...